Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure

JACC: Heart Failure

Volumn 1, Issue 3, 2013, Pages 252-258

  Sabbah, Hani N ^a   Wang, Mengjun ^a   Gupta, Ramesh C ^a   Rastogi, Sharad ^a   Ilsar, Itamar ^a   Sabbah, Michael S ^a   Kohli, Smita ^a   Helgerson, Sam ^b   Lee, Randall J ^c  

^a HENRY FORD HOSPITAL   (United States)

^b LoneStar Heart Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Congestive heart failure; Functional mitral regurgitation; Left ventricular function; Pressure volume relationship

Indexed keywords

ALGINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC IMPLANT; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DOG; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICULOGRAPHY; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ALGINATES; ANIMALS; CHRONIC DISEASE; DOGS; HEART FAILURE; HEART VENTRICLES; HYDROGEL; ORGAN SIZE; PROSTHESES AND IMPLANTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84878653063     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.02.006     Document Type: Article

References (26)

1. Braunwald E., Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 2000, 102:IV14-IV23.
2. Sabbah H.N., Kono T., Stein P.D., Mancini G.B., Goldstein S. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992, 263:H266-H270.
3. Douglas P.S., Morrow R., Ioli A., Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989, 13:311-315.
4. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004, 10:403-409.
5. Christman K.L., Lee R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006, 48:907-913.
6. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 2005, 46:714-719.
7. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 2006, 114:2627-2635.
8. Wenk J.F., Wall S.T., Peterson R.C., et al. A method for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns. J Biomech Eng 2009, 131:121011.
9. Yu J., Christman K.L., Chin E., Sievers R.E., Saeed M., Lee R.J. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2009, 137:180-187.
10. Sabbah H.N., Stein P.D., Kono T., et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991, 260:H1379-H1384.
11. Sabbah H.N., Shimoyama H., Kono T., et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994, 89:2852-2859.
12. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
13. Leor J., Tuvia S., Guetta V., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 2009, 54:1014-1023.
14. Mukherjee R., Zavadzkas J.A., Saunders S.M., et al. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann Thorac Surg 2008, 86:1268-1276.
15. Sadoshima J., Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 1993, 12:1681-1692.
16. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997, 100:2362-2370.
17. Sadoshima J., Qiu Z., Morgan J.P., Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res 1995, 76:1-15.
18. Sabbah H.N., Sharov V.G., Lesch M., Goldstein S. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem 1995, 147:29-34.
19. Sabbah H.N., Sharov V.G., Goldstein S. Cell death, tissue hypoxia and the progression of heart failure. Heart Fail Rev 2000, 5:131-138.
20. Kono T., Sabbah H.N., Rosman H., Alam M., Jafri S., Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992, 20:1594-1598.
21. Sabbah H.N. The cardiac support device and the myosplint: treating heart failure by targeting left ventricular size and shape. Ann Thorac Surg 2003, 75:S13-S19.
22. Sabbah H.N., Sharov V.G., Gupta R.C., et al. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res 2003, 93:1095-1101.
23. Klodell C.T., Aranda J.M., McGiffin D.C., et al. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device. J Thorac Cardiovasc Surg 2008, 135:188-195.
24. Mann D.L., Acker M.A., Jessup M., Sabbah H.N., Starling R.C., Kubo S.H. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann Thorac Surg 2007, 84:1226-1235.
25. Hagege A.A., Marolleau J.P., Vilquin J.T., et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006, 114:I108-I113.
26. Lee R.J., Hinson A., Helgerson S., Bauerschmitt R., Sabbah H.N. Polymer-based restoration of left ventricular mechanics. Cell Transpl 2013, 22:529-533.